Literature DB >> 10512812

Intersegment hydrogen bonds as possible structural determinants of the N/Q/R site in glutamate receptors.

D B Tikhonov1, B S Zhorov, L G Magazanik.   

Abstract

Specific electrophysiological and pharmacological properties of ionic channels in NMDA, AMPA, and kainate subtypes of ionotropic glutamate receptors (GluRs) are determined by the Asn (N), Gln (Q), and Arg (R) residues located at homologous positions of the pore-lining M2 segments (the N/Q/R site). Presumably, the N/Q/R site is located at the apex of the reentrant membrane loop and forms the narrowest constriction of the pore. Although the shorter Asn residues are expected to protrude in the pore to a lesser extent than the longer Gln residues, the effective dimension of the NMDA channel (corresponding to the size of the largest permeant organic cation) is, surprisingly, smaller than that of the AMPA channel. To explain this paradox, we propose that the N/Q/R residues form macrocyclic structures (rings) stabilized by H-bonds between a NH(2) group in the side chain of a given M2 segment and a C==O group of the main chain in the adjacent M2 segment. Using Monte Carlo minimization, we have explored conformational properties of the rings. In the Asn, but not in the Gln ring, the side-chain oxygens protruding into the pore may facilitate ion permeation and accept H-bonds from the blocking drugs. In this way, the model explains different electrophysiological and pharmacological properties of NMDA and non-NMDA GluR channels. The ring of H-bonded polar residues at the pore narrowing resembles the ring of four Thr(75) residues observed in the crystallographic structure of the KcsA K(+) channel.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10512812      PMCID: PMC1300473          DOI: 10.1016/S0006-3495(99)77033-5

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  58 in total

1.  Structural basis for explaining open-channel blockade of the NMDA receptor.

Authors:  M M Zarei; J A Dani
Journal:  J Neurosci       Date:  1995-02       Impact factor: 6.167

2.  Relative abundance of subunit mRNAs determines gating and Ca2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS.

Authors:  J R Geiger; T Melcher; D S Koh; B Sakmann; P H Seeburg; P Jonas; H Monyer
Journal:  Neuron       Date:  1995-07       Impact factor: 17.173

3.  Structural conservation of ion conduction pathways in K channels and glutamate receptors.

Authors:  M W Wood; H M VanDongen; A M VanDongen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

4.  Topology profile for a glutamate receptor: three transmembrane domains and a channel-lining reentrant membrane loop.

Authors:  J A Bennett; R Dingledine
Journal:  Neuron       Date:  1995-02       Impact factor: 17.173

5.  Acetylcholine receptor channel imaged in the open state.

Authors:  N Unwin
Journal:  Nature       Date:  1995-01-05       Impact factor: 49.962

6.  Molecular design of the N-methyl-D-aspartate receptor binding site for phencyclidine and dizolcipine.

Authors:  A V Ferrer-Montiel; W Sun; M Montal
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

7.  Structural determinants of the blocker binding site in glutamate and NMDA receptor channels.

Authors:  A V Ferrer-Montiel; J M Merino; R Planells-Cases; W Sun; M Montal
Journal:  Neuropharmacology       Date:  1998       Impact factor: 5.250

8.  Permeation and block of N-methyl-D-aspartic acid receptor channels by divalent cations in mouse cultured central neurones.

Authors:  M L Mayer; G L Westbrook
Journal:  J Physiol       Date:  1987-12       Impact factor: 5.182

9.  Dimensions of the narrow portion of a recombinant NMDA receptor channel.

Authors:  A Villarroel; N Burnashev; B Sakmann
Journal:  Biophys J       Date:  1995-03       Impact factor: 4.033

10.  Novel adamantane derivatives act as blockers of open ligand-gated channels and as anticonvulsants.

Authors:  S M Antonov; J W Johnson; N Y Lukomskaya; N N Potapyeva; V E Gmiro; L G Magazanik
Journal:  Mol Pharmacol       Date:  1995-03       Impact factor: 4.436

View more
  8 in total

1.  Studies of the structure of glutamate receptor ion channels and the mechanisms of their blockade by organic cations.

Authors:  L G Magazanik; D B Tikhonov; K V Bol'shakov; V E Gmiro; S L Buldakova; M V Samoilova
Journal:  Neurosci Behav Physiol       Date:  2003-03

2.  Ca2+-independent, but voltage- and activity-dependent regulation of the NMDA receptor outward K+ current in mouse cortical neurons.

Authors:  Tomomi Ichinose; Shun Yu; Xue Qing Wang; Shan Ping Yu
Journal:  J Physiol       Date:  2003-07-14       Impact factor: 5.182

3.  Modeling P-loops domain of sodium channel: homology with potassium channels and interaction with ligands.

Authors:  Denis B Tikhonov; Boris S Zhorov
Journal:  Biophys J       Date:  2004-10-08       Impact factor: 4.033

Review 4.  The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

Authors:  Lukas Wanka; Khalid Iqbal; Peter R Schreiner
Journal:  Chem Rev       Date:  2013-02-25       Impact factor: 60.622

5.  Modeling of the pore domain of the GLUR1 channel: homology with K+ channel and binding of channel blockers.

Authors:  Denis B Tikhonov; Jan R Mellor; Peter N R Usherwood; Lev G Magazanik
Journal:  Biophys J       Date:  2002-04       Impact factor: 4.033

6.  TRPV1 regulators mediate gentamicin penetration of cultured kidney cells.

Authors:  Sigrid E Myrdal; Peter S Steyger
Journal:  Hear Res       Date:  2005-06       Impact factor: 3.208

7.  High-affinity Zn block in recombinant N-methyl-D-aspartate receptors with cysteine substitutions at the Q/R/N site.

Authors:  M Amar; F Perin-Dureau; J Neyton
Journal:  Biophys J       Date:  2001-07       Impact factor: 4.033

Review 8.  P-Loop Channels: Experimental Structures, and Physics-Based and Neural Networks-Based Models.

Authors:  Denis B Tikhonov; Boris S Zhorov
Journal:  Membranes (Basel)       Date:  2022-02-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.